Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.
about
The continuing challenges of leprosyAbsence of gamma interferon and interleukin 2 production during active visceral leishmaniasisZanvil Alexander Cohn 1926-1993Pathogen-specific epitopes as epidemiological tools for defining the magnitude of Mycobacterium leprae transmission in areas endemic for leprosy.Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae.Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy.An analysis of in vitro T cell responsiveness in lepromatous leprosy.A model of human cytokine regulation based on transfection of gamma interferon gene fragments directly into isolated peripheral blood T lymphocytes.Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patientsImmunoregulatory biological response modifiers: effect of cytokines on septic shockIdentification of an immunostimulating protein from Mycobacterium lepraeInduction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium lepraeH-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin.Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation.Immune response in chronic Schistosomiasis haematobium and mansoni. Reversibility of alterations after anti-parasitic treatment with praziquantel.Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects.Immune mechanisms in inflammatory polyneuropathy.Immunological unresponsiveness in leprosy.Human T-cell clones with reactivity to Mycobacterium leprae as tools for the characterization of potential vaccines against leprosy.Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum.Hansen's disease as a research model.Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.A recombinant 64 kilodalton protein of Mycobacterium bovis bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens.Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticityImmunological responses in patients with tuberculosis and in vivo effects of acetyl-L-carnitine oral administration.Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients.Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy.Lepromatous leprosy treated with recombinant interferon gamma: cutaneous histologic changes.A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle.In situ characterization of the cutaneous immune response in Ethiopian cutaneous leishmaniasis.Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis.Cytokines in leprosy, I. Serum cytokine profile in leprosy.
P2860
Q24545809-6E8CC81D-6071-49FD-A280-AE913E0E60C3Q24563719-1A43C913-0E28-4093-A402-BFB629F21CAAQ24680249-7693F156-076B-4C81-AEEA-45463210A9C5Q34251374-ED7E7E11-4F91-4369-961C-CD071E40A6FFQ34297445-2114A866-B521-46A0-9E5C-B224373E59B1Q34313738-EADB7F6C-574E-4A75-853A-3559F76B17CDQ34627050-5B48080B-C9FF-4C83-9E54-CAF6609839DAQ35190753-952107FC-0EA3-42C2-895F-0C3B7D080DD8Q35382970-906D97B1-B218-48F1-AE64-609FBC512692Q36350785-E35E3651-864C-4688-8D63-C354FA8188EDQ36352606-75469D43-6F5A-4EAC-8E3D-4313D7EE9439Q36353218-5517294F-FA2C-4CEA-8EAD-B4CDB97046CAQ36627156-825A9701-69EC-48D6-8B60-8F7B2E9B21F3Q36978221-5EBDB36A-D734-4E07-8B1C-E964DE04CA43Q36997890-2B221C99-F98E-4874-BB2B-52D55326030FQ37002337-6400F75A-4A31-47CC-87DC-4B7366ABC4F1Q37056543-093C5D12-9155-4A8C-868E-1C8F05DDB131Q39001676-B55BB6F2-8080-4B8B-A718-C4BC243A1508Q39585296-1B76BA03-418B-48A7-AE4F-C90EE7458A29Q39607874-39D8D154-F55E-49CE-B9EA-A830983EE4D6Q40111877-195932D8-4037-4C6C-98DD-3CCE96781C54Q40165565-689B828D-D1F2-432D-944C-0F781498319CQ40166540-480A8F80-0F10-4D8D-BE9F-5B94FA9DF87FQ40189024-23BF961B-19CE-4071-8AF2-85492F6CB5B1Q40426840-2F4E608A-E7A3-453F-B8D6-0DDE8872AEF6Q41815508-AE1D371F-854C-45E7-94BD-9C467DD0AA33Q41882029-ECBF7F4B-E5E0-4DAD-89C0-15D847BC8780Q41901789-F02AA66C-A66F-46A7-BCF2-E065E4CFD81CQ42512070-5A5104A1-55F9-4EE0-94A9-E4F5DCAC09EEQ42774177-9EB41D0E-EACE-4901-8305-FA9A738045B1Q44175900-B2028C16-F518-42D8-A5FB-053F38FC6B6AQ45146970-16039EC7-A5BA-46C0-BB1E-7E55D4D9A47EQ46618327-5E3A574A-7FB0-4646-A7C7-2D7E131C2B44Q50233477-6B2FC235-C4EF-4E13-97E0-D381D411ECFFQ50859044-6A60DB0B-3474-4B7C-8C1A-E49D56B3D59C
P2860
Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Defective gamma interferon pro ...... ith antigen and interleukin 2.
@ast
Defective gamma interferon pro ...... ith antigen and interleukin 2.
@en
type
label
Defective gamma interferon pro ...... ith antigen and interleukin 2.
@ast
Defective gamma interferon pro ...... ith antigen and interleukin 2.
@en
prefLabel
Defective gamma interferon pro ...... ith antigen and interleukin 2.
@ast
Defective gamma interferon pro ...... ith antigen and interleukin 2.
@en
P2093
P2860
P356
P1476
Defective gamma interferon pro ...... ith antigen and interleukin 2.
@en
P2093
A Granelli-Piperno
N Nogueira
R Steinman
V Colomer Gould
P2860
P304
P356
10.1084/JEM.158.6.2165
P407
P577
1983-12-01T00:00:00Z